Report in English with a Dutch summary (KCE reports 45A)

More documents

Recommendations

Info

238 Screening for Colorectal Cancer KCE reports vol.45 386. Johnson CD, MacCarty RL, Welch TJ, Wilson LA, Harmsen WS, Ilstrup DM, et al. Comparison of the relative sensitivity of CT colonography and double-contrast barium enema for screen detection of colorectal polyps. Clin Gastroenterol Hepatol. 2004;2(4):314-21. 387. Blue Cross - Blue Shield Association. CT Colonography ( Virtual Colonoscopy ) for Colon Cancer Screening. Technology Evaluation Centre (TEC) Assessment Program. 2004;http://www.bcbs.com/tec/vol19/19_06.htm. 388. Rex DK, Vining D, Kopecky KK. An initial experience with screening for colon polyps using spiral CT with and without CT colography (virtual colonoscopy). Gastrointestinal Endoscopy. 1999;50(3):309-13. 389. Pineau BC, Paskett ED, Chen GJ, Espeland MA, Phillips K, Han JP, et al. Virtual colonoscopy using oral contrast compared with colonoscopy for the detection of patients with colorectal polyps. Gastroenterology. 2003;125(2):304-10. 390. Herrinton LJ, Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Case-control study of digital-rectal screening in relation to mortality from cancer of the distal rectum. Am J Epidemiol. 1995;142(9):961-4. 391. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36(6):2251-70. 392. Macrae FA, St John DJ. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology. 1982;82(5 Pt 1):891-8. 393. Grossman S, Milos ML, Tekawa IS, Jewell NP. Colonoscopic screening of persons with suspected risk factors for colon cancer: II. Past history of colorectal neoplasms. Gastroenterology. 1989;96(2 Pt 1):299-306. 394. Ransohoff DF, Lang CA. Small adenomas detected during fecal occult blood test screening for colorectal cancer. The impact of serendipity. JAMA. 1990;264(1):76-8. 395. Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJ. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg. 1997;84(12):1731-6. 396. Thomas WM, Hardcastle JD. Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia. Gut. 1990;31(11):1294-7. 397. Lindholm E, Berglund B, Kewenter J, Haglind E. Worry associated with screening for colorectal carcinomas. Scandinavian Journal of Gastroenterology. 1997;32(3):238-45. 398. Sharma VK, Corder FA, Fancher J, Howden CW. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test. Am J Gastroenterol. 2000;95(12):3629-32. 399. Sharma VK, Vasudeva R, Howden CW. Changes in colorectal cancer over a 15-year period in a single United States city. Am J Gastroenterol. 2000;95(12):3615-9. 400. Seeff LC, Shapiro JA, Nadel MR. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System. J Fam Pract. 2002;51(9):761-6. 401. Lieberman D. How to screen for colon cancer. Annu Rev Med. 1998;49:163-72. 402. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology. 1995;109(6):1781-90. 403. Vernon SW. Participation in colorectal cancer screening: a review. Journal of the National Cancer Institute. 1997;89(19):1406-22. 404. Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L. Adherence to continuous screening for colorectal neoplasia. Medical Care. 1993;31(6):508-19. 405. Blalock SJ, DeVellis BM, Afifi RA, Sandler RS. Risk perceptions and participation in colorectal cancer screening. Health Psychol. 1990;9(6):792-806. 406. Aiken LS, Fenaughty AM, West SG, Johnson JJ, Luckett TL. Perceived determinants of risk for breast cancer and the relations among objective risk, perceived risk, and screening behavior over time. Womens Health. 1995;1(1):27-50.
KCE reports vol.45 Screening for Colorectal Cancer 239 407. NCI. Theory at a Glance. A guide for Health Promotion Practice. 2005;NIH Publication(No. 05-3896). 408. Janz N, Becker M. The Health Belief Model: a decade later. Health Educ Q. 1984;11:1-47. 409. Lundh LG. Placebo, belief, and health. A cognitive-emotional model. Scand J Psychol. 1987;28(2):128-43. 410. Gillam SJ. Understanding the uptake of cervical cancer screening: the contribution of the health belief model. Br J Gen Pract. 1991;41(353):510-3. 411. Ronis DL. Conditional health threats: health beliefs, decisions, and behaviors among adults. Health Psychol. 1992;11(2):127-34. 412. Yarbrough SS, Braden CJ. Utility of health belief model as a guide for explaining or predicting breast cancer screening behaviours. J Adv Nurs. 2001;33(5):677-88. 413. Austin LT, Ahmad F, McNally MJ, Stewart DE. Breast and cervical cancer screening in Hispanic women: a literature review using the health belief model. Womens Health Issues. 2002;12(3):122-8. 414. Weinstein ND. Why it won't happen to me: perceptions of risk factors and susceptibility. Health Psychol. 1984;3(5):431-57. 415. Weinstein ND. The precaution adoption process. Health Psychol. 1988;7(4):355-86. 416. Monat A, Averill JR, Lazarus RS. Anticipatory stress and coping reactions under various conditions of uncertainty. J Pers Soc Psychol. 1972;24(2):237-53. 417. Lazarus RS. Psychological stress and coping in adaptation and illness. Int J Psychiatry Med. 1974;5(4):321-33. 418. Monat A. Temporal uncertainty, anticipation time, and cognitive coping under threat. J Human Stress. 1976;2(2):32-43. 419. Lazarus RS. Coping with the stress of illness. WHO Reg Publ Eur Ser. 1992;44:11-31. 420. Lazarus RS. Coping theory and research: past, present, and future. Psychosom Med. 1993;55(3):234-47. 421. Lazarus RS. Toward better research on stress and coping. Am Psychol. 2000;55(6):665-73. 422. Leventhal H, Cameron L. Behavioral theories and the problem of compliance. Patient Educ Couns. 1987;10:117 38. 423. Rippetoe PA, Rogers RW. Effects of components of protection-motivation theory on adaptive and maladaptive coping with a health threat. J Pers Soc Psychol. 1987;52(3):596-604. 424. Weinstein ND. Testing four competing theories of health-protective behavior. Health Psychol. 1993;12(4):324-33. 425. Sturges JW, Rogers RW. Preventive health psychology from a developmental perspective: an extension of protection motivation theory. Health Psychol. 1996;15(3):158-66. 426. Neuwirth K, Dunwoody S, Griffin RJ. Protection motivation and risk communication. Risk Anal. 2000;20(5):721-34. 427. Helmes AW. Application of the protection motivation theory to genetic testing for breast cancer risk. Prev Med. 2002;35(5):453-62. 428. Norman P, Searle A, Harrad R, Vedhara K. Predicting adherence to eye patching in children with amblyopia: an application of protection motivation theory. Br J Health Psychol. 2003;8(Pt 1):67-82. 429. Orbell S. Cognition and affect after cervical screening: the role of previous test outcome and personal obligation in future uptake expectations. Soc Sci Med. 1996;43(8):1237-43. 430. Baade PD, Steginga SK, Pinnock CB, Aitken JF. Communicating prostate cancer risk: what should we be telling our patients? Med J Aust. 2005;182(9):472-5. 431. Weinstein ND, Klein WM. Resistance of personal risk perceptions to debiasing interventions. Health Psychol. 1995;14(2):132-40.
Page 1 and 2:
Health Technology Assessment Colore
Page 3 and 4:
Health Technology Assessment Colore
Page 5 and 6:
KCE reports vol.45A Colorectale Kan
Page 7 and 8:
Page 9:
Page 12 and 13:
2 Screening for Colorectal Cancer K
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
10 Screening for Colorectal Cancer
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199: 188 Screening for Colorectal Cancer
Page 259 and 260: This page is left intentionally bla
Page 261: KCE reports 1. Effectiviteit en kos
show all

Report in English with a Dutch summary (KCE reports 45A)

Create successful ePaper yourself

Delete template?

Save as template?